Evaluation of the effect comorbid Parkinson syndrome on normal pressure hydrocephalus assessment
| Autor: | Lacie Manthripragada, Alexander Davis, Abhay Moghekar, Mark G. Luciano, Seema Gulyani, Sevil Yasar |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Wilcoxon signed-rank test Comorbidity Spinal Puncture Normal pressure hydrocephalus Internal medicine mental disorders medicine Humans Aged Retrospective Studies Past medical history medicine.diagnostic_test Lumbar puncture business.industry Medical record Parkinson Disease General Medicine Middle Aged medicine.disease Gait Hydrocephalus Normal Pressure Treatment Outcome Walk test Surgery Female Neurology (clinical) business Timed up and go |
| Zdroj: | Clinical neurology and neurosurgery. 207 |
| ISSN: | 1872-6968 |
| Popis: | Objective The primary aim of the study was to assess the effect comorbid Parkinson syndromes have on results of CSF tap test (TT) and shunt outcomes for patients presenting with Normal Pressure Hydrocephalus (NPH). We hypothesized that patients with possible NPH and comorbid Parkinson syndromes with Positive DaT scans will not respond to CSF TT at the same rate as patients without comorbid Parkinson syndromes. Additionally, we followed a small number of patients with positive DaT scans who were shunted to assess long term outcome of comorbid Parkinson syndromes. Methods Medical records and neurological exams of 251 patients were reviewed. In our analysis 101 patients with no parkinsonian symptoms and no DaT scans were included as a control group, there were 52 patients with DaT scans, 31 patients were positive (DaT-P). Gait measures were assessed before and after CSF TT using the Wilcoxon matched-pairs signed-rank test or paired t-tests were used. To compare the effect of DaT-P and Control, we used an ANCOVA controlling for age, sex, assistive device used, and past medical history effecting gait. Results There was not a significant difference in response between Control and DaT-P group. The Control group improved on timed up and go (TUG) by 14.82%, DualTUG 16.35%, 10-meter Walk Test (10MWT) 18.13%, MiniBEST 15.91%, and 6-minute Walk Test (6MWT) 13.96%, while the DaT-P group improved on TUG by 14.93%, DualTUG 17.24%, 10MWT 22.68%, MiniBEST 18.07%, and 6MWT 16.06%. Conclusion Our findings suggest that patients with possible NPH and suspected comorbid movement disorder, showed similar improvement after diagnostic CSF TT compared to participants with no parkinsonian symptoms present on exam. Data availability statement Data relevant to the study will be made available from the corresponding author upon a reasonable request. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect